Continuous Glucose Monitor Use in Pregnancy

Description

The purpose of this study is to perform a randomized controlled trial among 180 pregnant women with type 2 diabetes mellitus (T2DM) comparing continuous glucose monitor (CGM) use to the standard of care of multiple daily fingerstick glucose monitoring and its impact on large for gestational age infants, maternal glycemic control, patient satisfaction, and additional adverse perinatal outcomes.

Conditions

Type 2 Diabetes Treated With Insulin, Pregnancy, High Risk

Study Overview

Study Details

Study overview

The purpose of this study is to perform a randomized controlled trial among 180 pregnant women with type 2 diabetes mellitus (T2DM) comparing continuous glucose monitor (CGM) use to the standard of care of multiple daily fingerstick glucose monitoring and its impact on large for gestational age infants, maternal glycemic control, patient satisfaction, and additional adverse perinatal outcomes.

Continuous Glucose Monitor Use and Perinatal Outcomes Among Pregnant Women With Type 2 Diabetes Mellitus: A Randomized Controlled Trial

Continuous Glucose Monitor Use in Pregnancy

Condition
Type 2 Diabetes Treated With Insulin
Intervention / Treatment

-

Contacts and Locations

Worcester

University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States, 01605

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to

    Sexes Eligible for Study

    FEMALE

    Accepts Healthy Volunteers

    No

    Collaborators and Investigators

    University of Massachusetts, Worcester,

    Gianna L Wilkie, MD, PRINCIPAL_INVESTIGATOR, University of Massachusetts, Worcester

    Study Record Dates

    2027-07-01